GENE ONLINE|News &
Opinion
Blog

Series B Funding
Funding Series B FundingPrecision Oncology
Pfizer-backed Flare Taps Caris To Boost Precision Oncology Pipeline
2023-04-17
Funding Immunotherapy
Zenas Picks Up $118 Million To Advance Phase 3 For Autoimmune Candidate
2022-11-10
Funding Series B Funding
Delfi Diagnostics Amasses $225 Million for Early Cancer Screening
2022-07-19
China Series B Funding
Zhiyi Biotech Finishes Series B Funding With $45 Million For Live Biotherapeutics
2022-07-11
Funding Drug Delivery
ReCode Therapeutics’ Secures an Extra $120 Million To Support Its Drug Delivery Platform
2022-06-30
Funding Series B Funding
Dren Bio Draws $65 Million, Aiming for Phase 1 of ADCC Lead
2022-06-15
Funding Series B Funding
Elektrofi Secures $40 Million in Series B Funding For Drug Delivery Development
2022-06-15
Funding mRNA Technology
Singapore’s RVAC Medicines Raises $140 Million for mRNA Ambitions
2022-04-28
China Cancer
China’s InxMed Raises $50 Million to Inhibit Cancer-Resisting FAKs
2022-03-07
Funding Neurodegenerative Disease
Pfizer, Lilly-Backed Neuro Company Bags $64 Million Series B To Correct Progranulin Deficiency in Dementia
2022-02-11
Funding COVID-19
Google-Backed Leyden Labs Closes $140 Million Series B to Fight Viruses with Nasal Spray
2022-01-26
Funding RNA Editing
Korro Bio Raises $116 Million for RNA Editing Program
2022-01-06
Funding Precision Medicine
Acrivon Therapeutics to Advance Proteomics Platform & Oncology Pipeline with $100M Series B Financing
2021-11-12
Funding Lipid Nanoparticle
ReCode Therapeutics Raises $80 Million in Series B to Advance Gene Therapy & LNP Delivery Platform
2021-10-23
Funding Small Molecule Drug
ShouTi Raises $100M in Series B to “Replace Biologic Injections with Pills”
2021-10-21
1 2
LATEST
SURMOUNT-5 Trial: Zepbound Shows Greater Weight Loss Than Wegovy
2025-05-14
ASCGT Meeting Navigates Biotech Downturn After Multi-Year Slump
2025-05-14
Seasonal Skin Irritations Rise, Driving Demand for Accessible and Easy-to-Use Treatments
2025-05-14
Tirzepatide Users See 20.2% Average Weight Loss in Obesity Management Trial
2025-05-14
iMMagine-1 Phase 2 Study Provides Data on Investigational Matter Characteristics and Behavior
2025-05-14
Novo Nordisk Partners with Septerna in $2.2 Billion Deal to Develop Oral Obesity Drugs
2025-05-14
SMA: Researchers Explore In Utero Treatment Methods to Mitigate Muscle Weakness Before Birth
2025-05-14
READ MORE
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-26
2025 Antibody Therapeutic & Frontiers in Biomedical Sciences Conference
Taipei, Taiwan
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top